Search Results 31-40 of 9635 for Tuberculous lymphadenitis
Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...
Learn about the prevention and treatment of this disease that causes serious illness around the world.
The purpose of this study is to compare the diagnostic accuracy and potential predictive value of tuberculin skin test (TST) and interferon-g release assays ( ...
Tuberculosis (TB) is caused by the Mycobacterium tuberculosis (Mtb) bacilli, which is the leading infectious disease killer in the world and affects large ...
Jacksonville, Fla. The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. Molecular Analysis ...
Tuberculosis (TB) is a potentially serious infectious disease that mainly affects your lungs. Recommendations for who should be tested have changed over the ...
Tuberculosis is one of the world's deadly diseases. Each day, nearly 4,000 people lose their lives to TB and close to 28,000 people fall ill with this ...
The purpose of this study is to determine whether adding clofazimine in a treatment regimen for patients with non-tuberculous mycobacterial (NTM) infections ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.